Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Greg Siokas
Person

Greg Siokas

Tracked across 5 events · 33 articles · First seen Jun 01, 2026 · Last active Jun 11, 2026

Sentiment
30
Attention
4
Events
5
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (5)
4 60
Business
Cosmos Health Monetizes Non-Core Assets
Cosmos Health announced its intention to monetize approximately $20 million in non-core assets, including real estate such as the CosmoFarm distribution facility and Abbott Laboratories manufacturing site, as well as digital assets and marketable securities.…
Impact: Greg Siokas, CEO of Cosmos Health, announced the company's plan to monetize non-core assets, emphasizing the potential to unlock significant value for shareholders through acquisitions or debt reduction.
Jun 04, 2026 · 6 articles
2 30
Business
Cosmos Health acquires patent, expands nanotechnology
Cosmos Health Inc., through its wholly owned subsidiary Abbott Laboratories S.A., has acquired the international patent application WO2025108566A1 from Cloudpharm P.C. This acquisition is a strategic move to strengthen Cosmos Health's proprietary intellectual property portfolio…
Impact: Greg Siokas, CEO of Cosmos Health, commented on the acquisition, highlighting its role in strengthening the company's transition to proprietary product development and commercialization.
Jun 08, 2026 · 8 articles
2 40
Business
Cosmos Health launches veterinary C-Scrub
Cosmos Health>>> announced its entry into the global animal health market with the planned launch of a veterinary formulation of C-Scrub Wash 4%. This antimicrobial wash, already established for human use, successfully passed independent European…
Impact: Greg Siokas, CEO of Cosmos Health>>>, announced the successful testing and strategic importance of extending the C-Scrub brand into the veterinary sector.
Jun 01, 2026 · 7 articles
2 20
Business
Cosmos Health gets Nasdaq extension
Cosmos Health Inc. has been granted an additional 180-day period by Nasdaq-100, extending until December 7, 2026, to regain compliance with the minimum $1.00 bid price requirement. The company is compliant with all other Nasdaq-100…
Impact: Greg Siokas, CEO of Cosmos Health, expressed the company's preference to regain compliance without a reverse stock split, outlining their strategy to enhance shareholder value.
Jun 11, 2026 · 6 articles
2 0
Business
Cosmos Health expands Sky Premium Life EU
Cosmos Health>>> announced that its proprietary brand, Sky Premium Life>>>, has achieved pan-European distribution across all 27 European Union>>> Member States through the e-commerce platform Skroutz>>>. This expansion makes 96 Sky Premium Life>>> products accessible…
Impact: Greg Siokas>>>, CEO of Cosmos Health>>>, commented on the expansion, highlighting its importance for the company's international growth strategy and revenue goals.
Jun 04, 2026 · 6 articles
Key Actions (1)
80 Greg Siokas stated monetization plansCosmos Health Monetizes...
Relationships (4)
Cosmos Health ceo ↔ Greg Siokas Greg Siokas has served as the CEO of Cosmos Health since February 2016 and holds
Cosmos Health ↔ Greg Siokas
Abbott Laboratories ↔ Greg Siokas
Abbott Laboratories ↔ Greg Siokas
NEWSDESK
Track Greg Siokas live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.